New study to see if tezepelumab tames severe asthma in daily life
NCT ID NCT06566885
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 125 people aged 12 and older with severe asthma who are starting tezepelumab in Russia. Over 52 weeks, researchers will track how well their symptoms are controlled using a standard questionnaire. The goal is to see how the drug works outside of clinical trials, in real-world conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tezepelumab
What this could lead to
If successful, this study could show that tezepelumab helps people with severe asthma gain better symptom control in real-world settings.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It is also small (125 people) and limited to Russia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Kaliningrad, Russia
-
Research Site
Kemerovo, Russia
-
Research Site
Krasnodar, Russia
-
Research Site
Moscow, Russia
-
Research Site
Nal'chik, Russia
-
Research Site
Nizhny Novgorod, Russia
-
Research Site
Novosibirsk, Russia
-
Research Site
Orenburg, Russia
-
Research Site
Petrozavodsk, Russia
-
Research Site
Saint Petersburg, Russia
-
Research Site
Shelehov, Russia
-
Research Site
Stavropol, Russia
-
Research Site
Tomsk, Russia
-
Research Site
Ulan-Ude, Russia
-
Research Site
Yekaterinburg, Russia